GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glow LifeTech Corp (XCNQ:GLOW) » Definitions » EV-to-EBITDA

Glow LifeTech (XCNQ:GLOW) EV-to-EBITDA : -1.97 (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Glow LifeTech EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Glow LifeTech's enterprise value is C$2.46 Mil. Glow LifeTech's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was C$-1.25 Mil. Therefore, Glow LifeTech's EV-to-EBITDA for today is -1.97.

The historical rank and industry rank for Glow LifeTech's EV-to-EBITDA or its related term are showing as below:

XCNQ:GLOW' s EV-to-EBITDA Range Over the Past 10 Years
Min: -104.31   Med: 0   Max: 0.09
Current: -1.97

During the past 4 years, the highest EV-to-EBITDA of Glow LifeTech was 0.09. The lowest was -104.31. And the median was 0.00.

XCNQ:GLOW's EV-to-EBITDA is ranked worse than
100% of 456 companies
in the Biotechnology industry
Industry Median: 10.52 vs XCNQ:GLOW: -1.97

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Glow LifeTech's stock price is C$0.03. Glow LifeTech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.050. Therefore, Glow LifeTech's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Glow LifeTech EV-to-EBITDA Historical Data

The historical data trend for Glow LifeTech's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glow LifeTech EV-to-EBITDA Chart

Glow LifeTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
- - -1.36 -3.05

Glow LifeTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.59 -3.05 -3.12 -3.30 -2.94

Competitive Comparison of Glow LifeTech's EV-to-EBITDA

For the Biotechnology subindustry, Glow LifeTech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glow LifeTech's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glow LifeTech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Glow LifeTech's EV-to-EBITDA falls into.



Glow LifeTech EV-to-EBITDA Calculation

Glow LifeTech's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2.456/-1.248
=-1.97

Glow LifeTech's current Enterprise Value is C$2.46 Mil.
Glow LifeTech's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glow LifeTech  (XCNQ:GLOW) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Glow LifeTech's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.03/-0.050
=At Loss

Glow LifeTech's share price for today is C$0.03.
Glow LifeTech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Glow LifeTech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Glow LifeTech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Glow LifeTech (XCNQ:GLOW) Business Description

Traded in Other Exchanges
Address
65 International Boulevard, Suite 206, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption, and effectiveness. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Executives
Daniel Proska Director

Glow LifeTech (XCNQ:GLOW) Headlines

No Headlines